Epitalon (Epithalon)
Synthetic tetrapeptide, based on the natural pineal gland extract "epithalamin"
What It Is
A short synthetic peptide developed to reproduce the proposed activity of epithalamin, a pineal-gland-derived extract studied primarily by Russian researchers (notably at the St. Petersburg Institute of Bioregulation and Gerontology) in the context of aging research.
Proposed Mechanism
Proposed to influence telomerase activity and circadian/pineal signaling (e.g., melatonin regulation) — these are research hypotheses from a specific, relatively insular research tradition, not broadly replicated, independently-confirmed mechanisms.
Areas Researchers Are Investigating
- Telomere-length and cellular-aging research (mostly from the originating research group)
- Circadian rhythm / melatonin regulation research
- General longevity-research interest
Human Evidence
Some human studies exist, primarily from the originating Russian research group, generally older, smaller, and not replicated by large independent international trials at a scale comparable to FDA-approval-track compounds. This should be described honestly as limited and not independently well-replicated, rather than presented as strong evidence.
Animal / Preclinical Evidence
Includes animal-model aging and longevity research from the same research tradition.
Current FDA / Regulatory Status
Not FDA-approved. Not available as an approved drug in the US; sold in some other countries as a registered product under different regulatory regimes — regulatory status varies significantly by country and should be described precisely, not generalized.
Known Safety Information
No comprehensive, independently-replicated human safety database exists publicly at the scale expected for consumer guidance.
Limitations of Evidence
Research concentrated in one originating group/tradition; limited independent replication; older studies with smaller sample sizes; internationally inconsistent regulatory framing that content must not blur into an implied US approval.